Skip to main content

Specimen Collection Manual and Test Catalog

  or
  or
  or

CREATININE AND CYSTATIN C WITH EGFR

Geisinger Epic Procedure Code:  LAB4943    Geisinger Epic ID:  186451

SPECIMEN COLLECTION
Specimen type: 

Plasma or serum


Specimen required: 

2 mL serum or plasma; minimum 0.5 mL



SPECIMEN PROCESSING
Processing instructions: 

Allow serum to clot. Centrifuge to separate serum or plasma within 2 hours of collection.


Transport temperature: 

Refrigerated (2-8°C) preferred or frozen


Specimen stability: 

Room temperature or refrigerated: stable 7 days. Frozen serum stable 24 months for Cystatin C; 3 months for creatinine. Frozen plasma 6 months for Cystatin C, 3 months for creatinine.


Rejection criteria: 

Stability limits exceeded



TEST DETAILS
Reference interval: 

Cystatin C: 
18-49 years: 0.63-1.03 mg/L 
> or =50 years: 0.67-1.21 mg/L 
<18 years: Undefined 

Creatinine: 
Less than 2 years: 0.1-0.4 mg/dL 
2 years to <6 years: 0.2-0.5 mg/dL 
6 years to <10 years: 0.3-0.6 mg/dL 
10 years to <18 years: 0.4-1.0 mg/dL 
Females 18 years or older: 0.5-1.0 mg/dL 
Males 18 years or older: 0.6-1.2 mg/dL


Additional information: 

Estimated Glomerular Filtration Rate (eGFR) is calculated based on 2012 CKD-EPI Cystatin C equation and 2021 CKD-EPI equations. EGFR Calculator | National Kidney Foundation. eGFR >=60 mL/min is considered normal in most case.


CPT code(s):  82610, 82565
Note: The billing party has sole responsibility for CPT coding.  Any questions regarding coding should be directed to the payer being billed.
The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only.

Test includes: 

Cystatin C with Estimated GFR, Creatinine


Methodology: 
Enzymatic
Immunoturbidity
Synonyms: 

CysC, CREATB, Creatinine-S


Clinical significance: 

Serum Cystatin C with Creatinine is useful in the evaluation of kidney function. An estimated glomerular filtration rate (eGFR) will accompany all serum or plasma Cystatin C, Creatinine results.


Doctoral Director(s): 
Hoi-Ying Elsie Yu PhD, DABCC, FADLM
Review Date:  12/27/2024

Performing Locations